• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Supplemental Material: Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Publication
Peer-Reviewed
Evidence-Based OncologyFebruary 2021
Volume 27
Issue 2

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

Related Videos
Ciara Zachary, PhD, MPH
William Schpero, PhD, MPhil, MPH
Ciara Zachary, PhD, MPH
Chris Johnson, MBA
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.